BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 29420979)

  • 1. Multiparametric Prostate MR Imaging: Impact on Clinical Staging and Decision Making.
    Duvnjak P; Schulman AA; Holtz JN; Huang J; Polascik TJ; Gupta RT
    Radiol Clin North Am; 2018 Mar; 56(2):239-250. PubMed ID: 29420979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiparametric Prostate MR Imaging: Impact on Clinical Staging and Decision Making.
    Duvnjak P; Schulman AA; Holtz JN; Huang J; Polascik TJ; Gupta RT
    Urol Clin North Am; 2018 Aug; 45(3):455-466. PubMed ID: 30031465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparametric MR imaging of the Prostate: Pitfalls in Interpretation.
    Thomas S; Oto A
    Radiol Clin North Am; 2018 Mar; 56(2):277-287. PubMed ID: 29420982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiparametric prostate MRI: focus on T2-weighted imaging and role in staging of prostate cancer.
    Gupta RT; Spilseth B; Patel N; Brown AF; Yu J
    Abdom Radiol (NY); 2016 May; 41(5):831-43. PubMed ID: 27193786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Questions and answers on prostate multiparameter magnetic resonance imaging: Everything a urologist should know.
    Catalá V; Salas D; Esquena S; Mateu S; Algaba F; Palou J; de la Torre P
    Actas Urol Esp; 2016; 40(6):339-52. PubMed ID: 26920095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiparametric magnetic resonance imaging for transition zone prostate cancer: essential findings, limitations, and future directions.
    Lewis S; Besa C; Rosen A; Rastinehad AR; Semaan S; Hectors S; Taouli B
    Abdom Radiol (NY); 2017 Nov; 42(11):2732-2744. PubMed ID: 28702787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen.
    Radtke JP; Schwab C; Wolf MB; Freitag MT; Alt CD; Kesch C; Popeneciu IV; Huettenbrink C; Gasch C; Klein T; Bonekamp D; Duensing S; Roth W; Schueler S; Stock C; Schlemmer HP; Roethke M; Hohenfellner M; Hadaschik BA
    Eur Urol; 2016 Nov; 70(5):846-853. PubMed ID: 26810346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dramatic increase in the utilization of multiparametric magnetic resonance imaging for detection and management of prostate cancer.
    Oberlin DT; Casalino DD; Miller FH; Meeks JJ
    Abdom Radiol (NY); 2017 Apr; 42(4):1255-1258. PubMed ID: 27858090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate MR Imaging for Posttreatment Evaluation and Recurrence.
    Gaur S; Turkbey B
    Radiol Clin North Am; 2018 Mar; 56(2):263-275. PubMed ID: 29420981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiparametric Magnetic Resonance Imaging in Prostate Cancer Management: Current Status and Future Perspectives.
    Scheenen TW; Rosenkrantz AB; Haider MA; Fütterer JJ
    Invest Radiol; 2015 Sep; 50(9):594-600. PubMed ID: 25974203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latest Evidence on the Role of Multiparametric Magnetic Resonance Imaging in Active Surveillance for Insignificant Prostate Cancer: A Systematic Review.
    Cantiello F; Manno S; Russo GI; Cimino S; Privitera S; Morgia G; Cicione A; Damiano R
    Anticancer Agents Med Chem; 2018; 18(7):925-930. PubMed ID: 29303080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Imaging of locally advanced prostate cancer : Importance of ultrasound and especially MRI].
    Solyanik O; Schlenker B; Gratzke C; Ertl-Wagner B; Clevert DA; Stief C; Ricke J; Nörenberg D
    Urologe A; 2017 Nov; 56(11):1383-1393. PubMed ID: 28986612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Contemporary Role of Multiparametric Magnetic Resonance Imaging in Active Surveillance for Prostate Cancer.
    Schulman AA; Sze C; Tsivian E; Gupta RT; Moul JW; Polascik TJ
    Curr Urol Rep; 2017 Jul; 18(7):52. PubMed ID: 28589398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate Cancer Local Staging with Magnetic Resonance Imaging.
    Lin Y; Johnson LA; Fennessy FM; Turkbey B
    Radiol Clin North Am; 2024 Jan; 62(1):93-108. PubMed ID: 37973247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidance of treatment decisions in risk-adapted primary radiotherapy for prostate cancer using multiparametric magnetic resonance imaging: a single center experience.
    Panje C; Panje T; Putora PM; Kim SK; Haile S; Aebersold DM; Plasswilm L
    Radiat Oncol; 2015 Feb; 10():47. PubMed ID: 25880635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiparametric magnetic resonance imaging for prostate cancer: A review and update for urologists.
    Yoo S; Kim JK; Jeong IG
    Korean J Urol; 2015 Jul; 56(7):487-97. PubMed ID: 26175867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technique of Multiparametric MR Imaging of the Prostate.
    Purysko AS; Rosenkrantz AB
    Radiol Clin North Am; 2018 Mar; 56(2):211-222. PubMed ID: 29420977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiparametric MR Imaging for Detection and Locoregional Staging of Prostate Cancer.
    Bittencourt LK; de Hollanda ES; de Oliveira RV
    Top Magn Reson Imaging; 2016 Jun; 25(3):109-17. PubMed ID: 27187165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiparametric MR imaging of the Prostate: Interpretation Including Prostate Imaging Reporting and Data System Version 2.
    Furlan A; Borhani AA; Westphalen AC
    Radiol Clin North Am; 2018 Mar; 56(2):223-238. PubMed ID: 29420978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporating imaging into personalized medicine for the detection of prostate cancer: Pharmacological research-Urogenital pharmacology.
    Mertan F; Turkbey B
    Pharmacol Res; 2016 Dec; 114():163-165. PubMed ID: 27777131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.